国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (11): 871-876.doi: 10.3760/cma.j.issn.1673-422X.2013.11.021

• 论著 • 上一篇    下一篇

糖基因和N-糖链介导人肝癌细胞转移及耐药性的研究

金长宫, 冷文, 王华新
  

  1. 大连医科大学国有资产管理处维修科
  • 出版日期:2013-11-08 发布日期:2013-10-15
  • 通讯作者: 王华新,E-mail:whx124@163.comDepartment E-mail:whx124@163.com

Metastasis and drug resistance of human hepatocarcinoma cells mediated by glycogenes and N-glycans

JIN  Chang-Gong, LENG  Wen, WANG  Hua-Xin   

  1. of Maintenance Office of National Assets Control, Dalian Medical University, Dalian 116044, China
  • Online:2013-11-08 Published:2013-10-15
  • Contact: WANG Huaxin, E-mail: whx124@163.com E-mail:whx124@163.com

摘要: 目的通过研究糖基因、N-糖链在人肝癌高、低转移细胞株MHCC97-H和MHCC97-L中的差异表达,明确二者与肝癌转移及其耐药的相关性,确证肝癌转移诊断及抗肿瘤治疗新靶点。 方法采用实时荧光定量聚合酶链反应(real-time PCR)分析糖基因, 异硫氰酸荧光素(FITC)凝集素结合分析糖链的特征;通过RNA干扰技术干预差异表达的糖基因,检测干扰前后MHCC97-H细胞的体外侵袭力及其药物敏感性。进一步修饰N-糖基化(衣霉素和糖基肽酶处理),检测N-糖基化修饰前后MHCC97-H细胞的体外侵袭力、体内成瘤性及药物敏感性。结果糖基因、N-糖链在人肝癌高、低转移细胞株中表达差异有统计学意义;通过特异性RNA干扰技术使MHCC97-H细胞中N-乙酰氨基葡萄糖转移酶(MGAT5)表达下调时,该细胞在体外的侵袭能力下降, 药物敏感性增强(t=7.312, P﹤0.05)。MHCC97-H细胞经N-糖基化修饰后在体外的侵袭能力下降,体内成瘤性受到抑制,药物敏感性增强。结论人肝癌细胞中糖基因、糖蛋白N-糖链的差异表达与肿瘤细胞的转移及其耐药密切相关,可为肿瘤化疗提供新靶点。

关键词: 糖基转移酶类, 肝肿瘤, 肿瘤转移, 抗药性

Abstract: ObjectiveTo identify the relationship among glycogenes, N-glycans and hepatocarcinoma metastasis and drug resistance by studying the differential expressions of glycogenes and N-glycans in MHCC97-H and MHCC97-L human hepatocarcinoma cell lines, and to confirm the novel target of hepatocarcinoma metastasis and anti-tumor therapy. MethodsRealtime PCR was used to quantitatively analyze glycogenes and fluorescein isothiocyanate (FITC)lectin was used to analyze glycans characteristics. RNA interference approach was used to interfere the glycogenes, and the invasive ability in vitro and drug susceptibility of MHCC97-H cells were detected before and after interference. Modification of N-glycosylation (tunicamycin and PNGase F treatment) was done, and the invasiveness in vitro, tumorigenicity in vivo and drug susceptibility of MHCC97-H cells were detected before and after modification. ResultsThe expressions of glycogenes and glycans were different in MHCC97-H cells and MHCC97-L cells. The silence of MGAT5 in MHCC97-H cells inhibited invasion ability and increased sensitivity to 5-fluorouracil in vitro(t=7.312, P﹤0.05). Modification of N-glycosylation decreased MHCC97-H cells invasion ability in vitro and tumorigenicity in vivo and increased sensitivity to 5-fluorouracil. ConclusionThe differential expressions of glycogens and N-glycans in human hepatocarcinoma cell lines correlate with tumor invasion and drug resistance, and they are expected to be novel targets of tumor chemotherapy.

Key words: Glycosyltransferases, Liver neoplasms, Neoplasm metastasis, Drug resistance